• Price to book forward of Cogent Biosciences, Inc. – NASDAQ:COGT TradingView Thu, 09 Jul 2026 14:27:01 GMT
• Is Bezuclastinib’s FDA Filing And Disease-Modifying Data Altering The Investment Case For Cogent Biosciences (COGT)? simplywall.st Thu, 09 Jul 2026 02:43:54 GMT
• Cogent Biosciences (COGT) director takes options in lieu of cash Stock Titan Mon, 06 Jul 2026 20:31:32 GMT
• Cogent Biosciences (COGT) Edges Higher, Tests Key Resistance Amid Sector Tailwinds - Flat Correction dars.gov.et Mon, 06 Jul 2026 17:43:11 GMT
• enterprise value to revenue forward of cogent biosciences, inc. – nasdaq:cogt TradingView Sun, 05 Jul 2026 12:42:29 GMT
• 3 reasons cogent biosciences (cogt) looks pricey after its fda filing Sahm Fri, 03 Jul 2026 11:05:13 GMT
• 3 Reasons Cogent Biosciences (COGT) Looks Pricey After Its FDA Filing simplywall.st Thu, 02 Jul 2026 13:51:13 GMT
• how (cogt) movements inform risk allocation models Stock Traders Daily Tue, 30 Jun 2026 16:00:08 GMT
• Cogent Biosciences Submits US FDA New Drug Application for Potential Mast Cell Disease Treatment marketscreener.com Tue, 30 Jun 2026 13:10:13 GMT
• Cogent Biosciences (COGT) Submits NDA to FDA for Bezuclastinib GuruFocus Tue, 30 Jun 2026 12:48:11 GMT
• Why Cogent Biosciences (COGT) Is Up 6.7% After Russell Index Removal Reshapes Its Investor Base simplywall.st Tue, 30 Jun 2026 03:54:06 GMT
• Cogent Biosciences, Inc.(NasdaqGS:COGT) dropped from Russell Microcap Growth Benchmark Index marketscreener.com Mon, 29 Jun 2026 12:14:08 GMT
• cogent biosciences, inc. actuals & estimates (nasdaq:cogt) TradingView Mon, 29 Jun 2026 11:55:20 GMT
• Cogent Biosciences, Inc.(NasdaqGS: COGT) dropped from Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:39:12 GMT
• Cogent Biosciences, Inc.(NasdaqGS: COGT) dropped from Russell 3000 Value Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Cogent Biosciences, Inc.(NasdaqGS:COGT) dropped from Russell Small Cap Comp Value Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• cogent biosciences | 4: statement of changes in beneficial ownership of securities-director ros matthew Moomoo Sun, 28 Jun 2026 07:33:13 GMT
• cogent biosciences | 4: statement of changes in beneficial ownership of securities-director shegog todd Moomoo Sat, 27 Jun 2026 10:11:43 GMT
• cogent biosciences, inc. actuals & estimates (nasdaq:cogt) TradingView Fri, 26 Jun 2026 19:25:05 GMT
• cogent (cogt) presents preclinical data for novel jak2 inhibitor cgt1145 at 2026 eha congress Insider Monkey Wed, 24 Jun 2026 13:46:56 GMT
• Is Cogent Biosciences (COGT) ’s New Cancer Drug 100 Times More Precise Than What’s Already on the Market? Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• cogent biosciences inc (cogt) valuation: pe, pb & fair value analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• New Bezuclastinib and JAK2 Data Could Be A Game Changer For Cogent Biosciences (COGT) Sahm Sat, 20 Jun 2026 07:00:00 GMT
• wedbush maintains cogent biosciences(cogt.us) with buy rating, maintains target price $55 富途牛牛 Sat, 20 Jun 2026 04:01:30 GMT
• h.c. wainwright reiterates cogent stock rating on trial data by investing.com Investing.com Australia Fri, 19 Jun 2026 06:44:06 GMT
• h.c. wainwright reiterates cogent stock rating on trial data Investing.com UK Thu, 18 Jun 2026 15:05:30 GMT
• h.c. wainwright sticks to its buy rating for cogent biosciences (cogt) The Globe and Mail Thu, 18 Jun 2026 13:46:00 GMT
• cogent biosciences inc (cogt) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 09:27:48 GMT
• H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55 Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• cogent biosciences (cogt) stock can apex trial progress justify a 10.6x p b ratio simplywall.st Thu, 18 Jun 2026 07:00:00 GMT
• cogent biosciences inc (cogt) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 00:26:44 GMT
• cogent biosciences inc (cogt) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 23:11:56 GMT
• cogent biosciences inc (cogt) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 21:26:09 GMT
• cogent biosciences inc (cogt) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 21:25:59 GMT
• cogent biosciences inc (cogt) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:04:44 GMT
• cogent biosciences (cogt) gains 1.92% as biotech sector momentum builds - leveraged etf flow Město Břeclav Wed, 17 Jun 2026 18:38:24 GMT
• cogent biosciences inc (cogt) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 18:34:34 GMT
• cogent biosciences inc (cogt) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• cogent biosciences inc (cogt) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• cogent biosciences inc (cogt) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• cogent biosciences inc (cogt) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• stifel reiterates cogent stock buy rating after trial data by investing.com Investing.com India Mon, 15 Jun 2026 14:38:03 GMT
• Stifel Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $45 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• wedbush maintains cogent biosciences(cogt.us) with buy rating, maintains target price $55 富途牛牛 Mon, 15 Jun 2026 07:00:00 GMT
• Cogent Biosciences: A Pre-Commercial Biotech With Commercial-Stage Leverage (NASDAQ:COGT) Seeking Alpha Sun, 14 Jun 2026 07:00:00 GMT
• cogent biosciences, inc. (cogt) presents at european hematology association (eha) 2026 congress - slideshow Seeking Alpha Sat, 13 Jun 2026 07:00:00 GMT
• cogent biosciences (cogt) is up 6.7% after positive peak trial data and fda priority review - what's changed Sahm Sat, 13 Jun 2026 07:00:00 GMT
• cogent biosciences (cogt) is up 6.7% after positive peak trial data and fda priority review - what's changed simplywall.st Fri, 12 Jun 2026 22:29:24 GMT
• cogent biosciences unveils pivotal apex trial data at eha 2026 grafa.com Fri, 12 Jun 2026 14:40:54 GMT
• cogent unveils positive preclinical data for jak2 inhibitor cgt1145 grafa.com Fri, 12 Jun 2026 14:10:42 GMT
• cogent biosciences reveals promising preclinica... | pluang – crypto, stocks, gold & funds Pluang Fri, 12 Jun 2026 13:07:58 GMT
• cogent biosciences' potential rare blood disease treatment meets endpoints in clinical trial Moomoo Fri, 12 Jun 2026 12:58:30 GMT
• Cogent Biosciences Announces Preclinical Data from Novel GlobeNewswire Fri, 12 Jun 2026 07:00:00 GMT
• Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosi... GlobeNewswire Fri, 12 Jun 2026 07:00:00 GMT
• Experimental drug cuts mast cell disease markers in most AdvSM patients Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• experimental jak2 inhibitor targets mutation in most polycythemia vera cases Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• cogent biosciences shareholders back board, governance proposals The Globe and Mail Fri, 12 Jun 2026 07:00:00 GMT
• Cogent Biosciences (COGT) director linked to option grant for funds Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Cogent Biosciences (COGT) director receives 17,901 stock options at $31.98 strike Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Director for Cogent Biosciences (NASDAQ: COGT) granted 17,901 stock options Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Cogent Biosciences (COGT) director Arlene Morris receives grant of 17,901 stock options Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• director at cogent biosciences (nasdaq: cogt) receives 17,901 stock options Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• cogent biosciences | 4: statement of changes in beneficial ownership of securities-director harwin peter evan Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• cogent biosciences (nasdaq: cogt) 2026 meeting backs board, auditor and pay Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• how investors may respond to cogent biosciences (cogt) priority review for bezuclastinib gist regimen Yahoo Finance Wed, 10 Jun 2026 02:13:00 GMT
• cogent biosciences inc annual shareholders meeting transcript GuruFocus Tue, 09 Jun 2026 22:08:51 GMT
• How Investors May Respond To Cogent Biosciences (COGT) Priority Review For Bezuclastinib GIST Regimen Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• cogt: all proposals, including director elections and auditor ratification, were approved TradingView Tue, 09 Jun 2026 07:00:00 GMT
• assessing cogent biosciences (cogt) valuation after a strong one year run and cooling momentum Sahm Tue, 09 Jun 2026 07:00:00 GMT
• How Cogent Biosciences Inc. (COGT) Affects Rotational Strategy Timing Stock Traders Daily Mon, 08 Jun 2026 07:00:00 GMT
• Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now? Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• cogent biosciences (cogt) is down 7.3% after priority review win for bezuclastinib combo in gist - has the bull case changed? Sahm Sat, 06 Jun 2026 21:14:40 GMT
• cogent biosciences (cogt) is down 7.3% after priority review win for bezuclastinib combo in gist - has the bull case changed? simplywall.st Fri, 05 Jun 2026 07:31:59 GMT
• FDA Grants Priority Review to Bezuclastinib Plus Sunitinib for Patients With Advanced GIST Pharmacy Times – Pharmacy Practice News and Expert Insights Wed, 03 Jun 2026 07:00:00 GMT
• analysts are bullish on top healthcare stocks: agios pharma (agio), cogent biosciences (cogt) The Globe and Mail Tue, 02 Jun 2026 12:56:00 GMT
• analysts have conflicting sentiments on these healthcare companies: summit therapeutics (smmt), oculis holding (ocs) and cogent bi... The Globe and Mail Tue, 02 Jun 2026 11:04:00 GMT
• assessing cogent biosciences (cogt) valuation after peak phase 3 success and fda priority review simplywall.st Tue, 02 Jun 2026 07:35:51 GMT
• analysts offer insights on healthcare companies: cogent biosciences (cogt) and medline (mdln) The Globe and Mail Tue, 02 Jun 2026 01:44:00 GMT
• analysts offer insights on healthcare companies: nuvalent (nuvl), cogent biosciences (cogt) and anteris technologies global corp. ... The Globe and Mail Tue, 02 Jun 2026 01:12:00 GMT
• stifel maintains cogent biosciences(cogt.us) with buy rating, maintains target price $45 Moomoo Mon, 01 Jun 2026 13:31:00 GMT
• stifel reiterates cogent stock buy rating on gist drug data by investing.com Investing.com Australia Mon, 01 Jun 2026 12:24:08 GMT
• h.c. wainwright reiterates cogent stock rating on trial results Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• cogent biosciences stock surges 136%. investors see promise in its cancer drug. MSN Mon, 01 Jun 2026 06:24:09 GMT
• ubs maintains cogent biosciences(cogt.us) with buy rating, maintains target price $60 Moomoo Mon, 01 Jun 2026 01:31:00 GMT
• Cogent Biosciences (COGT) Reveals Promising Phase 3 Trial Results for Bezuclastinib GuruFocus Sun, 31 May 2026 07:00:00 GMT
• ubs maintains cogent biosciences(cogt.us) with buy rating, maintains target price $60 Moomoo Sun, 31 May 2026 07:00:00 GMT
• j.p. morgan maintains cogent biosciences(cogt.us) with buy rating Moomoo Sun, 31 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: staar surgical (staa), cogent biosciences (cogt) and glaxosmithkline (gsk) The Globe and Mail Sat, 30 May 2026 13:44:00 GMT
• cogent biosciences presented detailed clinical data from its peak phase iii trial at the 2026 american society of clinical oncolog... Bitget Sat, 30 May 2026 12:59:51 GMT
• Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Ga... Yahoo Finance Sat, 30 May 2026 07:00:00 GMT
• Cogent Biosciences Reports PEAK Phase 3 Trial Results Demonstrating Significant PFS Improvement with Bezuclastinib Combination in ... Quiver Quantitative Sat, 30 May 2026 07:00:00 GMT
• drug combo lets gist patients go 16.5 months before tumors worsen Stock Titan Sat, 30 May 2026 07:00:00 GMT
• cogent biosciences presented detailed clinical data from its peak phase iii trial at the 2026 american society of clinical oncolog... Bitget Fri, 29 May 2026 21:27:06 GMT
• cogt financials: revenue breakdown, margins & competitor comparison Intellectia AI Fri, 29 May 2026 19:36:36 GMT
• cogt reiterates by wedbush -- price target maintained at $55 GuruFocus Fri, 29 May 2026 16:33:06 GMT
• Wedbush Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55 Moomoo Fri, 29 May 2026 07:00:00 GMT
• hc wainwright & co. maintains cogent biosciences (cogt) buy recommendation MSN Fri, 29 May 2026 02:41:16 GMT
• exclusive bac article: cogent biosciences; pdufa bezuclastinib nonadvsm december 30th 2026, nda submission 1st half 2026 for advsm... Seeking Alpha Thu, 28 May 2026 18:48:06 GMT
• cogent biosciences announces participation in the 2026 jefferies global healthcare conference Sahm Thu, 28 May 2026 15:08:58 GMT
• (cogt) and the role of price-sensitive allocations Stock Traders Daily Thu, 28 May 2026 12:10:01 GMT
• Cogent Biosciences Announces FDA Acceptance of New Drug GlobeNewswire Thu, 28 May 2026 07:00:00 GMT
• Cancer drug combo halves disease progression risk in GIST trial Stock Titan Thu, 28 May 2026 07:00:00 GMT
• cogent bio granted fda priority review for lead asset in tumor indication Seeking Alpha Thu, 28 May 2026 07:00:00 GMT
• cogent biosciences (cogt) receives fda acceptance for new drug a GuruFocus Thu, 28 May 2026 07:00:00 GMT
• Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference Investing News Network Wed, 27 May 2026 07:00:00 GMT
• six new cogent biosciences hires get stock options and rsus Stock Titan Wed, 27 May 2026 07:00:00 GMT
• assessing cogent biosciences (cogt) valuation after a strong year and recent share price pullback Yahoo Finance Tue, 26 May 2026 00:18:00 GMT
• Assessing Cogent Biosciences (COGT) Valuation After A Strong Year And Recent Share Price Pullback Yahoo Finance Mon, 25 May 2026 07:00:00 GMT
• why is cogent biosciences stock up 4% today? by investing.com Investing.com Nigeria Fri, 22 May 2026 14:46:03 GMT
• cogent biosciences (cogt) ceo robbins gifts 320,000 shares in estate move Stock Titan Thu, 21 May 2026 07:00:00 GMT
• cogt sec filings - cogent biosciences inc 10-k, 10-q, 8-k forms Stock Titan Thu, 21 May 2026 02:38:30 GMT
• a look at cogent biosciences (cogt) valuation after new apex and jak2 data presentations are announced Sahm Sat, 16 May 2026 13:25:26 GMT
• could 2026 mark a transformational year for cogent biosciences? RTTNews Fri, 15 May 2026 07:00:00 GMT
• a look at cogent biosciences (cogt) valuation after new apex and jak2 data presentations are announced simplywall.st Fri, 15 May 2026 07:00:00 GMT
• cogent biosciences scores analyst praise as mastocytosis drug hits trial goals; retail buzz surges MSN Thu, 14 May 2026 16:35:19 GMT
• cogent biosciences (nasdaq: cogt) group reports 9,043,903 shares Stock Titan Thu, 14 May 2026 07:00:00 GMT
• cogt sec filings - cogent biosciences inc 10-k, 10-q, 8-k forms Stock Titan Tue, 12 May 2026 23:20:07 GMT
• advanced mastocytosis trial data and jak2 inhibitor at eha 2026 Stock Titan Tue, 12 May 2026 13:30:00 GMT
• Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• Cogent Biosciences Announces Presentations of Pivotal APEX Trial Data and JAK2 V617F Program at EHA Congress 2026 Quiver Quantitative Tue, 12 May 2026 07:00:00 GMT
• cogent biosciences (cogt) receives a rating update from a top analyst The Globe and Mail Mon, 11 May 2026 02:16:00 GMT
• cogent biosciences (cogt) receives a rating update from a top analyst The Globe and Mail Sun, 10 May 2026 07:00:00 GMT
• pier capital llc buys shares of 46,260 cogent biosciences, inc. $cogt MarketBeat Fri, 08 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: novo nordisk (nvo), onkure therapeutics (okur) and cogent biosciences (cogt) The Globe and Mail Thu, 07 May 2026 12:56:00 GMT
• piper sandler maintains cogent biosciences(cogt.us) with buy rating, maintains target price $52 Moomoo Thu, 07 May 2026 11:31:00 GMT
• cogent biosciences price target raised to $55 from $52 at h.c. wainwright TipRanks Thu, 07 May 2026 10:38:51 GMT
• lifesci capital maintains cogent biosciences(cogt.us) with buy rating, maintains target price $55 Moomoo Thu, 07 May 2026 08:31:00 GMT
• cogent biosciences (cogt) valuation after wider q1 loss and bezuclastinib regulatory progress Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• cogent biosciences, inc. $cogt shares purchased by vanguard group inc. MarketBeat Thu, 07 May 2026 07:00:00 GMT
• a quick look at today's ratings for cogent biosciences(cogt.us), with a forecast between $45 to $55 Moomoo Thu, 07 May 2026 04:26:57 GMT
Cogent Biosciences, Inc.(NASDAQ:COGT) 
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well...
Share this website to your friends